A study to assess whether an Artificial Intelligence (AI) technology can be used to assess images of suspicious skin lesions to determine the likelihood of skin cancer; and reduce the number, and cost assocated with, biopsies of skin lesions in primary care

Not Applicable

Recruiting

• Conditions: Skin Cancer; Skin - Dermatological conditions; Cancer - Malignant melanoma; Cancer - Non melanoma skin cancer

• Registration Number: ACTRN12619000398101
• Lead Sponsor: Skin Analytics Pty

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-12
• Last Update Posted: 21 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 750

Inclusion Criteria

Adult patients (18 years or older) who attend a primary care practice and have a clinical assessment of at least one suspicious skin lesion that is suitable for photographing (<15mm, in an anatomical site unsuitable for photographing, has previously been biopsied or in an area of visible scarring).

Exclusion Criteria

None

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of lesions GP chose to biopsy per skin cancer diagnosed, as captured in the patient record held by the GP[During GP appointment];Number of biopsies recommended by DERM per skin cancer diagnosed, as captured by the DERM system[During GP appointment]